Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-05-03 @ 7:27 AM
Study NCT ID:
NCT00470535
Status:
TERMINATED
Last Update Posted:
2017-02-23
First Post:
2007-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |